• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

糖尿病预防与控制的政策影响:来自伊朗的经验

Policy Implications for Diabetes Prevention and Control: An Experience from Iran.

作者信息

Peykari Niloofar, Ghaemi Fatemeh, Nasli Ensieh, Mahdavi Hazaveh Ali Reza, Yousefi Elham, Monji Hadi, Shadnoush Mahdi, Farzadfar Farshad, Larijani Bagher

机构信息

Deputy for Education, Ministry of Health and Medical Education, Tehran, Iran.

Deputy for Currative Affaire, Ministry of Health and Medical Education, Tehran, Iran.

出版信息

Med J Islam Repub Iran. 2022 Dec 27;36:178. doi: 10.47176/mjiri.36.178. eCollection 2022.

DOI:10.47176/mjiri.36.178
PMID:36908939
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9997414/
Abstract

Diabetes and its complications threaten the life of communities at global, national, and sub-national levels. Following the United Nations' call to action and develop a global action plan for the prevention and control of NCDs by The World Health Organization (WHO), all countries have a commitment to halt the rise in diabetes prevalence across the world. But the different situations of disease and risk factors, different priorities, and the context of the health care systems moved the countries to develop adapted targets and action plans. On the same ground, Iran established a national authority construction as the Diabetes Sub-committee which is part of the Iranian Non-Communicable Diseases Committee (INCDC) and incorporated a multi-sectoral mechanism to develop the national service framework for diabetes. Accordingly, this paper is aiming at sharing Iran's experience regarding the policy implications for diabetes prevention and control. Exchange this experience could be beneficiary to other countries to lead a systematic action to prevent disability and mortality due to diabetes.

摘要

糖尿病及其并发症在全球、国家和次国家层面威胁着社区居民的生命。响应联合国的行动号召,并根据世界卫生组织(WHO)制定的全球非传染性疾病预防和控制行动计划,所有国家都承诺阻止全球糖尿病患病率的上升。但由于疾病和风险因素的不同情况、不同的优先事项以及医疗保健系统的背景,各国制定了适应性目标和行动计划。基于同样的原因,伊朗设立了一个国家机构,即糖尿病小组委员会,作为伊朗非传染性疾病委员会(INCDC)的一部分,并纳入了一个多部门机制来制定国家糖尿病服务框架。因此,本文旨在分享伊朗在糖尿病预防和控制政策影响方面的经验。交流这一经验可能有助于其他国家开展系统性行动,以预防糖尿病导致的残疾和死亡。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/262e/9997414/582f22360286/mjiri-36-178-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/262e/9997414/582f22360286/mjiri-36-178-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/262e/9997414/582f22360286/mjiri-36-178-g001.jpg

相似文献

1
Policy Implications for Diabetes Prevention and Control: An Experience from Iran.糖尿病预防与控制的政策影响:来自伊朗的经验
Med J Islam Repub Iran. 2022 Dec 27;36:178. doi: 10.47176/mjiri.36.178. eCollection 2022.
2
National action plan for non-communicable diseases prevention and control in Iran; a response to emerging epidemic.伊朗非传染性疾病预防与控制国家行动计划;应对新出现的流行病。
J Diabetes Metab Disord. 2017 Jan 23;16:3. doi: 10.1186/s40200-017-0288-4. eCollection 2017.
3
A multi-sectoral approach to combatting non-communicable diseases: Iran's experience.一种应对非传染性疾病的多部门方法:伊朗的经验。
J Diabetes Metab Disord. 2019 Nov 23;18(2):719-720. doi: 10.1007/s40200-019-00466-3. eCollection 2019 Dec.
4
Policy implications for Road Safety: An Experience from Iran.道路安全的政策影响:来自伊朗的经验
Med J Islam Repub Iran. 2022 Dec 22;36:163. doi: 10.47176/mjiri.36.163. eCollection 2022.
5
Setting research priorities to achieve long-term health targets in Iran.确定研究重点以实现伊朗的长期健康目标。
J Glob Health. 2018 Dec;8(2):020702. doi: 10.7189/jogh.08.020702.
6
National Plan for Chronic Respiratory Diseases Prevention and Control in Iran.伊朗慢性呼吸道疾病预防与控制国家计划
Med J Islam Repub Iran. 2022 Dec 24;36:170. doi: 10.47176/mjiri.36.170. eCollection 2022.
7
Non-communicable diseases and health systems reform in low-and-middle-income countries.低收入和中等收入国家的非传染性疾病与卫生系统改革
Pac Health Dialog. 2012 Apr;18(1):179-90.
8
Policy analysis of nutrition stewardship for prevention and control of Non-communicable diseases in Iran.伊朗预防和控制非传染性疾病的营养管理政策分析。
BMC Health Serv Res. 2023 Jan 25;23(1):79. doi: 10.1186/s12913-023-09087-2.
9
Assessing Iran's health system according to the COVID-19 strategic preparedness and response plan of the World Health Organization: health policy and historical implications.根据世界卫生组织 COVID-19 战略准备和应对计划评估伊朗的卫生系统:卫生政策和历史意义。
J Prev Med Hyg. 2021 Jan 14;61(4):E508-E519. doi: 10.15167/2421-4248/jpmh2020.61.4.1613. eCollection 2020 Dec.
10
Population health and burden of disease profile of Iran among 20 countries in the region: from Afghanistan to Qatar and Lebanon.伊朗在该地区 20 个国家中的人口健康和疾病负担概况:从阿富汗到卡塔尔和黎巴嫩。
Arch Iran Med. 2014 May;17(5):336-42.

本文引用的文献

1
IDF Diabetes Atlas: Global, regional and country-level diabetes prevalence estimates for 2021 and projections for 2045.国际糖尿病联盟(IDF)糖尿病地图集:2021 年全球、区域和国家糖尿病患病率估算值以及 2045 年预测值。
Diabetes Res Clin Pract. 2022 Jan;183:109119. doi: 10.1016/j.diabres.2021.109119. Epub 2021 Dec 6.
2
Non-communicable Diseases and COVID-19; a double-edged sword A Special Communication from IRAN.非传染性疾病与新冠疫情:一把双刃剑 来自伊朗的特别通讯
J Diabetes Metab Disord. 2020 Nov 23;19(2):2057-2061. doi: 10.1007/s40200-020-00683-1. eCollection 2020 Dec.
3
A multi-sectoral approach to combatting non-communicable diseases: Iran's experience.
一种应对非传染性疾病的多部门方法:伊朗的经验。
J Diabetes Metab Disord. 2019 Nov 23;18(2):719-720. doi: 10.1007/s40200-019-00466-3. eCollection 2019 Dec.
4
Iran in transition.伊朗正在转型。
Lancet. 2019 May 11;393(10184):1984-2005. doi: 10.1016/S0140-6736(18)33197-0. Epub 2019 Apr 28.
5
Trend and projection of mortality rate due to non-communicable diseases in Iran: A modeling study.伊朗非传染性疾病死亡率的趋势和预测:一项建模研究。
PLoS One. 2019 Feb 14;14(2):e0211622. doi: 10.1371/journal.pone.0211622. eCollection 2019.
6
Forecasting life expectancy, years of life lost, and all-cause and cause-specific mortality for 250 causes of death: reference and alternative scenarios for 2016-40 for 195 countries and territories.预测 250 种死因的预期寿命、损失的生命年数以及全因和特定死因死亡率:2016-2040 年 195 个国家和地区的参考和替代情景。
Lancet. 2018 Nov 10;392(10159):2052-2090. doi: 10.1016/S0140-6736(18)31694-5. Epub 2018 Oct 16.
7
National action plan for non-communicable diseases prevention and control in Iran; a response to emerging epidemic.伊朗非传染性疾病预防与控制国家行动计划;应对新出现的流行病。
J Diabetes Metab Disord. 2017 Jan 23;16:3. doi: 10.1186/s40200-017-0288-4. eCollection 2017.
8
High Fasting Plasma Glucose Mortality Effect: A Comparative Risk Assessment in 25-64 Years Old Iranian Population.高空腹血糖死亡率效应:25 - 64岁伊朗人群的比较风险评估
Int J Prev Med. 2016 May 19;7:75. doi: 10.4103/2008-7802.182732. eCollection 2016.
9
Projection of Diabetes Population Size and Associated Economic Burden through 2030 in Iran: Evidence from Micro-Simulation Markov Model and Bayesian Meta-Analysis.基于微观模拟马尔可夫模型和贝叶斯荟萃分析的伊朗 2030 年糖尿病患病人群规模及相关经济负担预测
PLoS One. 2015 Jul 22;10(7):e0132505. doi: 10.1371/journal.pone.0132505. eCollection 2015.